Search research articles
Contact Us
Filters
Showing results (1-10 of 13) with videos related to
Page
of 2
Sort By:
Blood
|
July 10, 2013
Conditional ablation of LYVE-1+ cells unveils defensive roles of lymphatic vessels in intestine and lymph nodes
Jeon Yeob Jang, Young Jun Koh, Seung-Hun Lee, et al.
European Journal of Cancer (Oxford, England : 1990)
|
September 23, 2023
A phase II study on the efficacy of regorafenib in treating patients with c-KIT-mutated metastatic malignant melanoma that progressed after previous treatment (KCSG-UN-14-13)
Kyoo Hyun Kim, Minkyu Jung, Hyo Jin Lee, et al.
Clinical Breast Cancer
|
April 16, 2026
Subtype-Specific Risk and Temporal Dynamics of Brain Metastases in Metastatic Breast Cancer
Kyoo Hyun Kim, Joohyuk Sohn, Min Hwan Kim, et al.
Cellular Oncology (Dordrecht, Netherlands)
|
November 18, 2021
Inhibition of the bromodomain and extra-terminal family of epigenetic regulators as a promising therapeutic approach for gastric cancer
Sun Kyoung Kang, Hyun Joo Bae, Woo Sun Kwon, et al.
Biochemical Pharmacology
|
November 8, 2020
p16 methylation is a potential predictive marker for abemaciclib sensitivity in gastric cancer
Hyun Joo Bae, Sun Kyoung Kang, Woo Sun Kwon, et al.
Journal of Cellular and Molecular Medicine
|
September 25, 2018
Regulation of proliferation and invasion by the IGF signalling pathway in Epstein-Barr virus-positive gastric cancer
Inhye Jeong, Sun Kyoung Kang, Woo Sun Kwon, et al.
Cancer Research and Treatment
|
July 21, 2023
A Phase II Trial of Nintedanib in Patients with Metastatic or Recurrent Head and Neck Squamous Cell Carcinoma: In-Depth Analysis of Nintedanib Arm from the KCSG HN 15-16 TRIUMPH Trial
Kyoo Hyun Kim, Sun Min Lim, Hee Kyung Ahn, et al.
The Oncologist
|
March 12, 2024
Exploring Molecular Genetic Alterations and RAF Fusions in Melanoma: A Belvarafenib Expanded Access Program in Patients with RAS/RAF-Mutant Melanoma
Kyoo Hyun Kim, Sungmin Cho, Yeyeong Jeong, et al.
Journal of the American Academy of Dermatology
|
September 6, 2022
First-line pembrolizumab versus dabrafenib/trametinib treatment for BRAF V600-mutant advanced melanoma
Chang Gon Kim, Miso Kim, Jieon Hwang, et al.
Cancer Research and Treatment
|
February 4, 2025
Differential Efficacy of Alpelisib by PIK3CA Mutation Site in Head and Neck Squamous Cell Carcinoma: An Analysis from the KCSG HN 15-16 TRIUMPH Trial
Kyoo Hyun Kim, Shinwon Hwang, Min Kyoung Kim, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 13) with videos related to
Sort By:
Page
of 2
Blood
|
July 10, 2013
Conditional ablation of LYVE-1+ cells unveils defensive roles of lymphatic vessels in intestine and lymph nodes
Jeon Yeob Jang, Young Jun Koh, Seung-Hun Lee, et al.
European Journal of Cancer (Oxford, England : 1990)
|
September 23, 2023
A phase II study on the efficacy of regorafenib in treating patients with c-KIT-mutated metastatic malignant melanoma that progressed after previous treatment (KCSG-UN-14-13)
Kyoo Hyun Kim, Minkyu Jung, Hyo Jin Lee, et al.
Clinical Breast Cancer
|
April 16, 2026
Subtype-Specific Risk and Temporal Dynamics of Brain Metastases in Metastatic Breast Cancer
Kyoo Hyun Kim, Joohyuk Sohn, Min Hwan Kim, et al.
Cellular Oncology (Dordrecht, Netherlands)
|
November 18, 2021
Inhibition of the bromodomain and extra-terminal family of epigenetic regulators as a promising therapeutic approach for gastric cancer
Sun Kyoung Kang, Hyun Joo Bae, Woo Sun Kwon, et al.
Biochemical Pharmacology
|
November 8, 2020
p16 methylation is a potential predictive marker for abemaciclib sensitivity in gastric cancer
Hyun Joo Bae, Sun Kyoung Kang, Woo Sun Kwon, et al.
Journal of Cellular and Molecular Medicine
|
September 25, 2018
Regulation of proliferation and invasion by the IGF signalling pathway in Epstein-Barr virus-positive gastric cancer
Inhye Jeong, Sun Kyoung Kang, Woo Sun Kwon, et al.
Cancer Research and Treatment
|
July 21, 2023
A Phase II Trial of Nintedanib in Patients with Metastatic or Recurrent Head and Neck Squamous Cell Carcinoma: In-Depth Analysis of Nintedanib Arm from the KCSG HN 15-16 TRIUMPH Trial
Kyoo Hyun Kim, Sun Min Lim, Hee Kyung Ahn, et al.
The Oncologist
|
March 12, 2024
Exploring Molecular Genetic Alterations and RAF Fusions in Melanoma: A Belvarafenib Expanded Access Program in Patients with RAS/RAF-Mutant Melanoma
Kyoo Hyun Kim, Sungmin Cho, Yeyeong Jeong, et al.
Journal of the American Academy of Dermatology
|
September 6, 2022
First-line pembrolizumab versus dabrafenib/trametinib treatment for BRAF V600-mutant advanced melanoma
Chang Gon Kim, Miso Kim, Jieon Hwang, et al.
Cancer Research and Treatment
|
February 4, 2025
Differential Efficacy of Alpelisib by PIK3CA Mutation Site in Head and Neck Squamous Cell Carcinoma: An Analysis from the KCSG HN 15-16 TRIUMPH Trial
Kyoo Hyun Kim, Shinwon Hwang, Min Kyoung Kim, et al.
Page
of 2